LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema
Recruiting · NCT05601037 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Ghent
View the official record on ClinicalTrials.gov →Interventions studied
Axilla dissection + Lymphovenous anastomosis
What this trial is about
Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.
Who can take part
Age range
18 Years to 99 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- lymph node + breast cancer requiring dissection
Exclusion criteria
- previous lymphedema
- BMI \>35
Where it is running
1 location listed.
- UZ GENT - Ghent, Oost-Vlaanderen, Belgium